Gretarsdottir S, Tryggvadottir L, Jonasson J G, Sigurdsson H, Olafsdottir K, Agnarsson B A, Ogmundsdottir H, Eyfjörd J E
Molecular and Cell Biology Research Laboratory, Icelandic Cancer Society, Reykjavik, Iceland.
Br J Cancer. 1996 Aug;74(4):555-61. doi: 10.1038/bjc.1996.400.
The aim of this investigation was to examine the possibility of analysing TP53 mutations in archival paraffin-embedded material with the constant denaturant gel electrophoresis (CDGE) method. We extracted DNA from 193 archival primary breast carcinoma samples, diagnosed in 1981-83; further analysis was possible for 186 of these. TP53 mutations in exons 5-8 were detected with CDGE in 30 samples (16.1%) and 17 of these mutations were confirmed by sequencing. Immunohistochemistry demonstrated TP53 nuclear accumulation in 58 tumours (31%). A strong association between the presence of TP53 mutations and TP53 immunostaining was observed (P < 0.001). Our mutation and immunohistochemistry results are in agreement with other findings based on fresh tumour tissue. TP53 abnormalities were significantly related to high S-phase fraction, low oestrogen receptor (ER) content and high tumour grade. Survival of patients with TP53 abnormalities, in the group as a whole, did not differ from patients with normal TP53. Our study did, however, show that patients with abnormal TP53 had a significantly shorter post-recurrence survival (P = 0.005) than patients with normal TP53.
本研究的目的是探讨采用恒定变性剂凝胶电泳(CDGE)方法分析存档石蜡包埋材料中TP53突变的可能性。我们从1981 - 1983年诊断的193份存档原发性乳腺癌样本中提取了DNA;其中186份样本可进行进一步分析。通过CDGE在30份样本(16.1%)中检测到外显子5 - 8的TP53突变,其中17个突变经测序得以确认。免疫组织化学显示58个肿瘤(31%)中存在TP53核聚集。观察到TP53突变的存在与TP53免疫染色之间存在强关联(P < 0.001)。我们的突变和免疫组织化学结果与基于新鲜肿瘤组织的其他研究结果一致。TP53异常与高S期分数、低雌激素受体(ER)含量和高肿瘤分级显著相关。总体而言,TP53异常患者的生存率与TP53正常患者并无差异。然而,我们的研究确实表明,TP53异常的患者复发后的生存期明显短于TP53正常的患者(P = 0.005)。